Location
Please check the individual session for location or broadcast availability.
Frequency
Semi-monthly
Series Director
Xander Wehrens, MD, PhD
Series Co-Director
Biykem Bozkurt, MD, PhD
Target Audience
Needs Statement
Learners require targeted education to expand their knowledge of the pathophysiology and physiology of cardiovascular disease, the mechanisms of cardiovascular science and clinical studies, the analysis and interpretation of results, and the integration of findings into science and clinical practice. The series will address the need for deeper knowledge of emerging biomarkers, therapeutic targets, and the limitations of preclinical and clinical studies in predicting treatment efficacy and safety. A focus of the series will be to discuss the basic science underlying cardiovascular clinical studies and professional guidelines and thereby promote a wider dissemination of this information to achieve evidence-based patient care. By presenting focused lectures on current research, the series aims to equip clinicians, scientists, and trainees with the tools to critically evaluate new data and apply it to improve patient outcomes.
Educational Methods
Educational methods will include lectures.
Objectives
At the conclusion of the session, the participants should be able to:
- Identify gaps in medical knowledge that negatively affect patient care in cardiology.
- Recognize new research areas with translational potential, including novel biomarkers and therapeutic targets.
- Discuss new research findings that may influence clinical practice and improve outcomes in cardiovascular medicine.
Evaluation
Participants may be asked to complete a session evaluation.
Accreditation/Credit Designation
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Facebook
X
LinkedIn
Forward